Home | Welcome to Contract Pharma   
Last Updated Friday, July 25 2014
Print

Search Results for 'Financial Reports'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Gil Roth
Published February 6, 2014
Generics drive sales down, more layoffs planned Read More »
By Gil Roth
Published February 6, 2014
Diabetes, Genzyme, Generics key drivers Read More »
By Gil Roth
Published February 6, 2014
Generic exclusivity boosts 4Q revenues Read More »
By Gil Roth
Published February 5, 2014
Botox, eye care drugs fuel growth Read More »
By Gil Roth
Published February 5, 2014
Growth pushed by Late-Stage Development segment Read More »
By Gil Roth
Published February 5, 2014
Stribild, Complera/Eviplera drive growth Read More »
By Gil Roth
Published February 5, 2014
Singulair, other patent expirations weigh on revenues Read More »
By Michael Martorelli
Published November 6, 2009
Feel Better Now? Ending one year, approaching the next By Michael A. Martorelli It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
Top 25 Pharma and Biopharma Report
Published July 21, 2014
Big Pharma continues to face the impact of competitive pressures, fluctuating currencies, the patent cliff, and pipeline surprises, all of which were reflected in financial results last year. Read More »
By Kristin Brooks
Published February 20, 2014
Revenues up 15% in the quarter Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On